scispace - formally typeset
P

Patricia Price

Researcher at Curtin University

Publications -  310
Citations -  8309

Patricia Price is an academic researcher from Curtin University. The author has contributed to research in topics: Immune system & Haplotype. The author has an hindex of 42, co-authored 298 publications receiving 7913 citations. Previous affiliations of Patricia Price include Royal Perth Hospital & Concord Repatriation General Hospital.

Papers
More filters
Journal ArticleDOI

Immune restoration disease after antiretroviral therapy.

TL;DR: Differentiation of IRD from an opportunistic infection is important because IRD indicates a successful, albeit undesirable, effect of HAART, and it is also important to differentiateIRD from drug toxicity to avoid unnecessary cessation ofHAART.
Journal ArticleDOI

The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases

TL;DR: Several candidate genes in the central MHC have the potential to modulate immune or inflammatory responses in an antigen‐independent manner, as is seen in studies of cultured cells from healthy carriers of the 8.1 AH.
Journal ArticleDOI

Immune restoration disease after the treatment of immunodeficient HIV‐infected patients with highly active antiretroviral therapy

TL;DR: A single‐centre retrospective study of all HIV‐infected patients commencing HAART prior to 1 July 1997 was undertaken to determine the incidence, characteristics and time of onset of disease episodes in HAART responders.
Journal ArticleDOI

Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction.

TL;DR: The data suggest that up regulation of RANKL mRNA in both inflammatory cells and epithelium may be associated with the activation of osteoclastic bone destruction in periodontitis.
Journal Article

An evaluation of the efficacy of methods used in screening for lower-limb arterial disease in diabetes. Authors' reply

TL;DR: Screening tools that are effective in screening for lower-limb PAOD in the nondiabetic population are less efficacious in diabetes, particularly in the presence of detectable peripheral neuropathy.